CinCor
fund manager
sector
Healthcare
geography
North America
Vintages
status
Transfer
category
#Unicorn

CinCor

Co-invested company
Cincor is an American biopharmaceutical company developing the next generation of treatments for hypertension and cardio-renal diseases.
Design representing CinCor, part of the Private Equity manager's portfolio General Atlantic

CinCor key figures

2018
year established
193 M$
raised since its creation
1,8 bn
purchase price by AstraZeneca
Data at
4/10/24
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About CinCor

CinCor is a biopharmaceutical company focused on the development of baxdrostat, a drug to treat hypertension and certain cardio-renal diseases.

Baxdrostat has been designed to use a differentiated mechanism of action, direct inhibition of aldosterone synthase production, to provide improved treatment for patients suffering from hypertension or high blood pressure, a condition affecting up to 20% of the world's population.

The company, founded by Jon Isaacsohn and Catherine Pearce, is looking to transform its promising clinical trials into market-ready pharmaceutical products. Once approved, CinCor's treatments will improve the lives of patients suffering from cardio-renal disease.

In the same sector as CinCor

Company videos
No items found.
Discover our exclusive services
General Atlantic
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio